Brind.

Nationwide Recall Issued for Blood Pressure Medication Manufactured in India

Steady: 0 in the last 7 days Updated oct 21

The latest in this situation

  1. Indian products were subject to an FDA recall.
  2. An alert regarding a product recall originated in the manufacturer's country, involving Idaho and India.

How it started

1 report, 1 independent, last reported Oct 5. The briefing below covers this first event.

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A nationwide recall of a high blood pressure medication has been announced by its manufacturer. The drug, chlorthalidone tablets, was made by Inventia Healthcare Limited in India. The company voluntarily recalled the product because it would not dissolve properly after ingestion, potentially leading to less potency and danger to users. Over 13,000 bottles were flagged under Class II recall with batch identification number RISA2400.

From mix106radio.com

Why it matters

Some supportBrind's analysis of the reports

The recall concerns a medication used to treat high blood pressure, a condition that affects many adults in the United States. The manufacturer stated the drug might not react as designed in the body, which could put users' lives in danger.

From mix106radio.com

Who's involved

  • IdahoThe primary market focus for the recalled medication.
  • IndiaThe country of origin for the manufacturer of the affected drug.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • IndiaSpeculative

    The manufacturer could face increased liability and potential revenue loss due to the product failure.

How it developed

Newest first. Tap a step to see who reported it.
  1. Indian products were subject to an FDA recall.Sub-event
  2. Product recall alert originated in the manufacturer's country.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped